Archives gene-therapy

by in
Entry Author Date Location
Dimension, Backed by Fidelity, Targets Hemophilia With Gene Therapy 10/31/13 Boston
San Diego Life Sciences Roundup: IPOs, Illumina, KFx Medical, & More 10/17/13 San Diego
Celgene Emerges as Biotech’s Shrewdest, Nimblest Dealmaker 08/05/13 National
Audentes, Loaded With $30M, Pursues Gene Therapy for Rare Diseases 07/26/13 San Francisco
Sangamo in Race to Replace Chronic Drug Treatment with Gene Therapies 07/15/13 San Francisco
Trusting Your Partners: A Chat With Celgene’s George Golumbeski 07/11/13 New York
Bluebird Prices Ahead of Range, Takes Flight on Nasdaq Today 06/19/13 Boston
Q&A With Bob Tepper on What’s Next for Third Rock Ventures 03/26/13 Boston
East Coast Biotech Roundup: Moderna, bluebird, Blueprint 03/22/13 Boston
SD Life Sciences Roundup: Celladon, Vertex, MediciNova, & More 05/10/12 San Diego
San Diego’s Celladon Extends Round to $53M, Opens European Office 05/08/12 San Diego
BioPharma Needs A Safe, Reliable Way To Repair Broken Genes 04/11/12 Seattle
SD Life Sciences Roundup: Celladon, Gen-Probe, Organovo, and More 02/16/12 National
RetroSense Therapeutics Licenses Vision Restoration Technology From Wayne State 11/01/11 Detroit
Upping the Ante: San Diego Life Sciences Startups Raise More Cash 09/07/11 San Diego
Biotech is Biggest Winner in Second-Quarter VC Funding, Zogenix Strategy Unfolds, Intellikine Builds Clinical Trial Capabilities, & More San Diego Life Sciences News 07/21/11 San Diego
Neurologix Forges Ahead on Gene Therapy Treatment for Parkinson’s 06/23/11 New York
Vertex Gets FDA OK, Alnylam Plans For ASCO, Biogen Drug Advances in Europe, & More Boston-Area Life Sciences News 05/27/11 Boston
Bluebird Bio Looks to Move Past Hot Papers, Charge Ahead in Clinic With Gene Therapy 05/23/11 Boston
Sangamo Shows Early Promise Against HIV, Hemophilia at Gene Therapy Revival Meeting 05/23/11 San Francisco
The Resurgence of Gene and Cell Therapy 05/16/11 Seattle
Bluebird Bio Snaps up $30M for Gene Therapies, Adds ARCH Venture to Syndicate 04/20/11 Boston
Bluebird Bio Inks AFM Development Deal 03/16/11 Boston
Gates Amps Up Biotech Investment, Calypso Seeks Rebound, Targeted Genetics’ Obit, & More Seattle-Area Life Sciences News 03/10/11 Seattle
Targeted Genetics, Re-invented as AmpliPhi, Bets on Anti-Bacterials, Moves HQ to London 03/09/11 Seattle
Stewart Parker Joins IDRI as New CEO, Bringing Biotech Sensibility to Global Health Effort 02/15/11 Seattle
Dendreon Survives Medicare Panel, Arch’s Ouch, RNAi Shock Wave Hits Tekmira, & More Seattle-Area Life Sciences News 11/18/10 Seattle
Targeted Genetics Seeks Merger 11/12/10 Seattle
Ceregene Adds $11.5M 11/11/10 San Diego
Sangamo, With a Lock on Genetic Switch Technology, Seeks to Morph Into Drugmaker 10/18/10 San Francisco
Page 3 of 5 « previous page · next page »